Vaxcyte Inc (PCVX NASDAQ) stock market data APIs
$59.8471
-1.23(-2.1%)
as of March 9, 2026
Try our APIs with
free plan!
Vaxcyte Inc Financial Data Overview
Price chart is built with
Anychart
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Prev. Close
59.8471
Open
58.6155
High
60.4719
Low
57.9817
52 wk Range
27.66-76.61
Market Cap
8 609 M
Shares Outstanding
144 M
EPS
-1.8
Beta
1.382
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Vaxcyte Inc (top by weight)
Ticker
100-day Price Change
Weight
W311.XETRA
HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Accumulating
-0.63
(-8.73%)
4.85
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Vaxcyte Inc data using free add-ons & libraries
Get Vaxcyte Inc Fundamental Data
Vaxcyte Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -907 278 976
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-02
- EPS/Forecast: -1.47
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vaxcyte Inc News
New
Does Heavy 2025 Loss and Large Equity Raise for Vaxcyte’s VAX-31 Shift the Bull Case (PCVX)?
Vaxcyte, Inc. reported a full-year 2025 net loss of US$766.63 million, with basic loss per share from continuing operations of US$5.63, and simultaneously moved to strengthen its balance sheet through...
Love A Little Risk? Wall Street Sees Massive Upside in Vaxcyte Stock.
Vaxcyte (PCVX) is a clinical-stage vaccine innovation company focused on developing next-generation vaccines to protect people from serious bacterial infectious diseases. While Vaxcyte is still a clin...
Vaxcyte Advances VAX-31 Toward Phase 3 As Valuation Gap Persists
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Vaxcyte (NasdaqGS:PCVX) reported unprecedented Phase 2 results in adults for its 31-valent ...
A Look At Vaxcyte (PCVX) Valuation As Share Price Momentum Rebuilds
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Vaxcyte (PCVX) has been drawing attention after recent share price moves, with the s...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
